Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. [electronic resource]
Producer: 20171018Description: e186-95 p. digitalISSN:- 2352-3026
- Acetanilides -- administration & dosage
- Aged
- Antineoplastic Agents -- administration & dosage
- Canada
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- France
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Treatment Outcome
- United Kingdom
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.